Literature DB >> 28619550

New discoveries in the pathogenesis and classification of vitiligo.

Michelle Rodrigues1, Khaled Ezzedine2, Iltefat Hamzavi3, Amit G Pandya4, John E Harris5.   

Abstract

Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy depigmentation. This disfiguring condition frequently affects the face and other visible areas of the body, which can be psychologically devastating. The onset of vitiligo often occurs in younger individuals and progresses for life, resulting in a heavy burden of disease and decreased quality of life. Presentation patterns of vitiligo vary, and recognition of these patterns provides both diagnostic and prognostic clues. Recent insights into disease pathogenesis offer a better understanding of the natural history of the disease, its associations, and potential for future treatments. The first article in this continuing medical education series outlines typical and atypical presentations of vitiligo, how they reflect disease activity, prognosis, and response to treatment. Finally, we discuss disease associations, risk factors, and our current understanding of disease pathogenesis.
Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.

Entities:  

Keywords:  chemical leukoderma; confetti depigmentation; halo nevi; leukoderma; segmental vitiligo; vitiligo; vitiligo pathogenesis

Mesh:

Year:  2017        PMID: 28619550     DOI: 10.1016/j.jaad.2016.10.048

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  59 in total

Review 1.  Thyroid diseases and skin autoimmunity.

Authors:  Enke Baldini; Teresa Odorisio; Chiara Tuccilli; Severino Persechino; Salvatore Sorrenti; Antonio Catania; Daniele Pironi; Giovanni Carbotta; Laura Giacomelli; Stefano Arcieri; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

2.  Inflammatory Vitiligo.

Authors:  Hua-Ching Chang; Chun-Yu Lai; Yin-Shuo Chang
Journal:  Dermatol Pract Concept       Date:  2022-07-01

3.  Vitiligo of the arm after COVID-19 vaccination.

Authors:  Rhea Singh; Jay L Cohen; Michael Astudillo; John E Harris; Esther E Freeman
Journal:  JAAD Case Rep       Date:  2022-06-20

4.  Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients.

Authors:  Efrat Fleissig; Mor Pavlovksy; Anat Loewenstein; Dinah Zur; Hadas Newman; Shay Keren; Dafna Goldenberg; Efrat Bar-Ilan; Michaella Goldstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-16       Impact factor: 3.117

5.  Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors.

Authors:  Pietro Sollena; Vasiliki Nikolaou; Nikolaos Soupos; Elias Kotteas; Dimitra Voudouri; Alexandros J Stratigos; Davide Fattore; Maria Carmela Annunziata; Armando Orlandi; Lucia Di Nardo; Zoe Apalla; Florian Deilhes; Maria Concetta Romano; Gabriella Fabbrocini; Vincent Sibaud; Ketty Peris
Journal:  Breast Cancer Res Treat       Date:  2020-09-10       Impact factor: 4.872

6.  Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China.

Authors:  Li Zhang; Shujun Chen; Yuli Kang; Xiuxiu Wang; Fang Yan; Min Jiang; Qianqian Wang; Ziqi Liu; Chengfeng Zhang; Leihong Xiang
Journal:  JAMA Dermatol       Date:  2020-03-01       Impact factor: 10.282

Review 7.  An overview of the efficacy of phototherapy in oncodermatology.

Authors:  Candice Park; Abraham M Korman; Brittany L Dulmage
Journal:  Support Care Cancer       Date:  2022-02-02       Impact factor: 3.603

Review 8.  Updates and new medical treatments for vitiligo (Review).

Authors:  David Emmanuel Kubelis-López; Natalia Aranza Zapata-Salazar; Salvador Luis Said-Fernández; Celia Nohemí Sánchez-Domínguez; Mauricio Andrés Salinas-Santander; Herminia Guadalupe Martínez-Rodríguez; Osvaldo Tomás Vázquez-Martínez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

9.  Epidemiology of Vitiligo - A Dual Population-Based Approach.

Authors:  Nicole Mohr; Jana Petersen; Natalia Kirsten; Matthias Augustin
Journal:  Clin Epidemiol       Date:  2021-05-26       Impact factor: 4.790

10.  SFRP5 inhibits melanin synthesis of melanocytes in vitiligo by suppressing the Wnt/β-catenin signaling.

Authors:  Dao-Pei Zou; Yang-Mei Chen; Ling-Zhao Zhang; Xiao-Hui Yuan; Yu-Jie Zhang; Adelina Inggawati; Pham Thi Kieu Nguyet; Tian-Wen Gao; Jin Chen
Journal:  Genes Dis       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.